Linkage Projects - Grant ID: LP100200129

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP100200129

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Using the eye as a window to the central nervous system for improved drug testing. The annual cost of treating brain illnesses is US$250 billion. Each new drug costs about US$900 million to develop. This research will give Pfizer Pty Ltd, the project’s industry partner, a more efficient and direct way of testing whether drugs can get into and affect the brain. This will reduce the cost of drug development, which ultimately means cheaper drugs. The project will develop new technologies to put Australia at the forefront of neuropharmaceutical and neuroscience research. A new research platform will foster collaborations with the pharmaceutical industry both within Australia and overseas. This industrial link will promote a unique post-graduate experience by providing exposure to academic and industrial environments for Australian scientists.

Funded Activity Details

Start Date: 29-11-2010

End Date: 31-12-2015

Funding Scheme: Linkage Projects

Funding Amount: $625,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Vision Science | Medical Biotechnology Diagnostics (incl. Biosensors) | Sensory Systems | Neurosciences

ANZSRC Socio-Economic Objective (SEO)

Diagnostic Methods | Nervous System and Disorders | Hearing, Vision, Speech and Their Disorders |

Other Keywords

Diagnostic Methods | Hearing, Vision, Speech and Their Disorders | Medical Biotechnology Diagnostics (incl. Biosensors) | Nervous System and Disorders | Neurosciences | Sensory Systems | Vision Science

Related Links